Univo Pharmaceuticals Ltd
TLV: UNVO.TA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tel Aviv Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Golan Bitton
- Employees
- 76
- Headquarters
- Ashkelon, Israel
- IPO year
- 2010
- Market cap
- ILA 287.3M
- Website
- https://www.unv-medicine.com
Loading UNVO…
Loading profile data…Frequently asked questions about UNVO
What does Univo Pharmaceuticals Ltd (UNVO.TA) do?
Univo Pharmaceuticals Ltd engages in the development, production, and supply of medical cannabis products. The company was formerly known as Di-Pharm Ltd and changed its name to Univo Pharmaceuticals Ltd in September 2018. Univo Pharmaceuticals Ltd was incorporated in 1993 and is based in Ashkelon, Israel.
Where does UNVO.TA trade?
Univo Pharmaceuticals Ltd (UNVO.TA) trades on the Tel Aviv Stock Exchange.
What sector is UNVO.TA in?
Univo Pharmaceuticals Ltd (UNVO.TA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Univo Pharmaceuticals Ltd?
Golan Bitton is the chief executive officer of Univo Pharmaceuticals Ltd (UNVO.TA).
Where is Univo Pharmaceuticals Ltd headquartered?
Univo Pharmaceuticals Ltd is headquartered in Israel.
Does UNVO.TA pay a dividend?
Univo Pharmaceuticals Ltd (UNVO.TA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did UNVO.TA go public?
Univo Pharmaceuticals Ltd (UNVO.TA) completed its initial public offering in 2010.